Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Merigan

Showing results (31-40 of 366) with videos related to

Pageof 37
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1978
Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humansL Rasmussen, T C Merigan
AIDS (London, England)|January 1, 1995
AIDS 1995. Clinical treatment: overviewJ Weber, T C Merigan
Nature|October 28, 1982
Immunoregulation by gamma-interferon?T Basham, T C Merigan
Annals of the New York Academy of Sciences|January 1, 1979
A regulatory role for interferon in immunityG Sonnenfeld, T C Merigan
The American Journal of Medicine|May 21, 1990
Safety and tolerance of dideoxycytidine as a single agent. Results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex. Study Group of the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious DiseasesT C Merigan, G Skowron
Reviews of Infectious Diseases|September 1, 1990
Cytomegalovirus: where have we been and where are we going?T C Merigan, S Resta
Journal of Interferon Research|January 1, 1980
Effect of interferon therapy on circulating lymphocytes in humansL Rasmussen, T C Merigan
CRC Critical Reviews in Clinical Laboratory Sciences|June 1, 1972
Interferon and its inducers: antiviral and other effectsR Rodgers, T C Merigan
The American Journal of Medicine|May 21, 1990
Alternating and intermittent regimens of zidovudine (3'-azido-3'-deoxythymidine) and dideoxycytidine (2',3'-dideoxycytidine) in the treatment of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complexG Skowron, T C Merigan
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1988
Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccinesA Weinberg, T C Merigan
Pageof 37

Showing results (31-40 of 366) with videos related to

Sort By:
Pageof 37
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1978
Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humansL Rasmussen, T C Merigan
AIDS (London, England)|January 1, 1995
AIDS 1995. Clinical treatment: overviewJ Weber, T C Merigan
Nature|October 28, 1982
Immunoregulation by gamma-interferon?T Basham, T C Merigan
Annals of the New York Academy of Sciences|January 1, 1979
A regulatory role for interferon in immunityG Sonnenfeld, T C Merigan
The American Journal of Medicine|May 21, 1990
Safety and tolerance of dideoxycytidine as a single agent. Results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex. Study Group of the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious DiseasesT C Merigan, G Skowron
Reviews of Infectious Diseases|September 1, 1990
Cytomegalovirus: where have we been and where are we going?T C Merigan, S Resta
Journal of Interferon Research|January 1, 1980
Effect of interferon therapy on circulating lymphocytes in humansL Rasmussen, T C Merigan
CRC Critical Reviews in Clinical Laboratory Sciences|June 1, 1972
Interferon and its inducers: antiviral and other effectsR Rodgers, T C Merigan
The American Journal of Medicine|May 21, 1990
Alternating and intermittent regimens of zidovudine (3'-azido-3'-deoxythymidine) and dideoxycytidine (2',3'-dideoxycytidine) in the treatment of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complexG Skowron, T C Merigan
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1988
Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccinesA Weinberg, T C Merigan
Pageof 37